cemiplimab
Regeneron
['empower-cervical 1', 'platinum', 'cemiplimab', 'medsir']
dr shares os data of empower-cervical 1 in pts with recurrent or metastatic cervical cancer after 1l platinum-based chemo. cemiplimab significantly improved os vs chemo in scc and overall population lowering risk of death by 31% and 34%, regardless pd-l1 status #esmo22 
Bring your idea to life??Creating successful IITs & optimal drug development??Medica Scientia Innovation Research????????https://t.co/cciUf0lqpM